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a  b  s  t  r  a  c  t
Genus  Aloe,  Xanthorrhoeaceae,  is  well  distributed  all  over Egypt,  and  many  species  have  been  used
as  medicinal  plants;  mainly  reported  to prevent  cardiovascular  diseases,  cancer  and  diabetes.  This  study
attempts  to  analyze  the  secondary  metabolites  in the  methanol  extract  of  the  leaves  of eight  Aloe  species;
A.  vera  (L.) Burm.  f., A. arborescens  Mill.,  A.  eru  A. Berger,  A. grandidentata  Salm-Dyck,  A. perfoliata  L.,  A. brevi-
folia Mill.,  A.  saponaria  Haw.  and  A.  ferox  Mill.  growing  in  Egypt.  For  this  aim HPLC–DAD–MS/MS  in negative
ion mode  was  used.  Although  belonging  to  the  same  genus,  the  composition  of each  species  presented  dif-
ferent particularities.  Seventy  one  compounds  were  identiﬁed  in  the  investigated  Aloe  species,  of which
cis-p-coumaric  acid  derivaties,  3,4-O-(E)  caffeoylferuloylquinic  acid and  caffeoyl  quinic  acid  hexoside
were  the  most  common  phenolic  acids  identiﬁed.  Aloeresin  E and  isoaloeresin  D, 2′-O-feruloylaloesin
were  the common  anthraquinones  identiﬁed.  Lucenin  II, vicenin  II, and  orientin  were  the  common
identiﬁed  ﬂavonoids  in the  investigated  Aloe  species.  6′-Malonylnataloin,  aloe-emodin-8-O-glucoside,
ﬂavone-6,8-di-C-glucosides could  be  considered  as  chemotaxonomic  markers  for  the  investigated  Aloe
species.  The  eight  Aloe  species  had  signiﬁcant  anti-inﬂammatory  activity,  in  addition  to the  signiﬁcant
acceleration  of diabetic  wound  healing  in  rats  following  topical  application  of the  methanol  extracts  of
their  leaves.  This is  the  ﬁrst simultaneous  characterization  and  qualitative  determination  of multiple  phe-
nolic compounds  in Aloe  species  from  locally  grown  cultivars  in  Egypt  using  HPLC–DAD–MS/MS,  which
can  be  applied  to standardize  the quality  of different  Aloe  species  and  the  future  design  of  nutraceuticals
and  cosmetic  preparations.
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The genus Aloe L. (family Xanthorrhoeaceae, subfamily Aspho-
eloideae) is an old world genus which comprises more than
00 species, which has centers of diversity in southern and east
frica and Madagascar (Newton, 2004). Aloe is used as a traditional
edicine for treatment of different diseases, as ingredients of food
roducts and cosmetics (Eshun and He, 2004). Phenolic compounds
ncluding chromones, anthraquinones, and pyrones constitute the
ajor secondary metabolites of Aloe (Conner et al., 1990; Okamura
t al., 1998; Durì et al., 2004). Most of these compounds have been
eported to possess several biological activities such as antitumor,
ntidiabetic and antityrosinase, in addition to the antiulcer activ-
ty (Imanishi et al., 1981; Yagi et al., 1987; Beppu et al., 1993;
eradaira et al., 1993). Some components isolated from Aloe species
ere reported to possess anti-inﬂammatory effect for example; an
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effective anti-inﬂammatory cinnamoyl-C-glucosyl-chromone has
been isolated from Aloe barbadensis (Hutter et al., 1996). Moreover,
the wound-healing properties of A. barbadensis was also reported
(Davis et al., 1989).
The phytochemical constituents and bioactivity of Aloe spp. have
attracted research interest since the trade in ‘drug aloes’, prepared
from the leaf exudate, expanded rapidly in the nineteenth century
(Yeats, 1870). Today, the principal sources of these natural products
are wild populations of Aloe ferox in South Africa, and Aloe scabrifo-
lia, Aloe secundiﬂora and Aloe turkanensis in east Africa (Oldﬁeld,
2004). Moreover, Aloe vera, the source of the leaf parenchyma
known as ‘aloe gel’, is widely cultivated.
Aloe leaves in addition of being of pharmacological importance,
their chemistry have systematic signiﬁcance, particularly at the
infrageneric rank. Secondary metabolites proﬁle was used in the
evaluation of infrageneric groups such as series Longistylae, section
Pachydendron,  section Anguialoe and series Purpurascentes Salm-
Dyck (Van Heerden et al., 1996; Reynolds, 1997; Viljoen and Van
Wyk, 2001). Phytochemical data may  offer a tool to study the
complexity of maculate species, which comprise about 40 species
ditora Ltda. This is an open access article under the CC BY-NC-ND license
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o-named because of their conspicuous leaf markings. Although
t is widely regarded as a well-supported group, infrageneric
oundaries and species delimitation in the maculate complex are
roblematic (Grace et al., 2008).
For this purpose we have started a detailed screening of eight
loe species; A. vera (L.) Burm. f., A. arborescens Mill., A. eru A.
erger, A. grandidentata Salm-Dyck, A. perfoliata L., A. brevifolia
ill., A. saponaria Haw. and A. ferox Mill growing in Egypt; using
PLC coupled to electrospray ionization mass spectrometry (ESI-
S)  [HPLC–DAD–ESI–MS/MS] with the aim of identifying unique
onstituents which may  be used as markers with possible chemo-
axonomic signiﬁcance. In addition, to evaluate the diabetic wound
ealing and anti-inﬂammatory effects of the eight Aloe species in
ats using the diabetic wound model and carrageenan-induced paw
dema tests.
xperimental
lant material
The leaves of the eight Aloe species, A. vera (L.) Burm. f., A.
rborescens Mill., A. eru A. Berger, A. grandidentata Salm-Dyck, A.
erfoliata L., A. brevifolia Mill., A. saponaria Haw. and A. ferox Mill.
ere collected in April 2014 from El-Orman Garden, Giza, Egypt.
he plants were authenticated by Dr. Reem Samir Hamdy, Lecturer
f Plant Taxonomy, Botany Department, Faculty of Science, Cairo
niversity, Giza, Egypt. Voucher samples no. 2014422 of the plants
ere deposited at the Museum of the Pharmacognosy Department,
aculty of Pharmacy, Cairo University.
xtraction
The fresh leaves of the eight Aloe species (500 g each) were
ut into pieces and extracted with methanol using cold method
f extraction (percolation) (4× 2 l) till exhaustion. The methanol
xtract in each case was ﬁltered, distilled and evaporated under
educed pressure to give 12.65, 12.44, 5.21, 20.02, 6.97, 6.94, 3.86
nd 3.96 g of A. vera, A. arborescens, A. eru, A. grandidentata,  A. per-
oliata,  A. brevifolia, A. saponaria and A. ferox, respectively.
ualitative determination of the phenolic contents of Aloe
eaves using HPLC–DAD–ESI-MS/MS
ample preparation
Aloe extracts were separately dissolved in HPLC grade
ethanol in a concentration of 10 mg/ml  then ﬁltrated through a
yringe-ﬁlter-membrane. Aliquots of 5 l were injected into the
C–DAD/MS Dionex Ultimate 3000 HPLC (Germany), used for per-
orming the analyses.
PLC conditions
The method of El Maggar (2012) was employed. HPLC apparatus
Hewlett-Packard 1100, Waldbronn, Germany) with a quater-
ary pump and on line degasser was employed for analysis. A
hermostatted column compartment with an auto sampler, a pho-
odiode array detector (DAD). The separation was  performed on
clipse XDB C18 column (50 mm × 2.1 mm,  1.8 m,  Agilent Com-
any, USA). 1100 ChemStation software was used. The mobile
hase was composed of two solvents, A: methanol and B: 0.2%
ormic acid in water. Gradient elution proﬁle was performed: 0 min,
:B 10:90; 36 min, A:B 100:0; 40 min, A:B 100:0. Chromatography
as performed at 30 ◦C with a ﬂow-rate of 0.2 ml/min. UV traces
ere measured at 290, 254 and 350 nm and UV spectra (DAD) were
ecorded between 190 and 900 nm.armacognosia 26 (2016) 352–362 353
Mass spectrometric conditions
Electrospray ionization (ESI) interfaced Bruker Daltonik
Esquire-LC ion trap mass spectrometer (Bremen, Germany) and
an Agilent HP1100 HPLC system were used for HPLC–MS analysis.
An autosampler and a UV–vis absorbance detector were used.
The ionization parameters were as follows: capillary voltage
4000 V, end plate voltage −500 V; nebulizing gas of nitrogen at
35.0 p.s.i.; drying gas of 10 l/min nitrogen at 350 ◦C. Mass analyzer
scanned from 15 to 1000 u. The MS–MS  spectra were recorded
in auto-MS–MS mode. The fragmentation amplitude was set to
1.0 V. MS2  data. Mass spectra were simultaneously acquired using
electrospray ionization in the negative ionization mode.
Chemicals
Dermazine® cream (silver sulfadiazine) was used as a stan-
dard wound healing drug. Indomethacin (Indomethacin)®, Eipico,
Egyptian Int. Pharmaceutical Industries Co. was  used as a stan-
dard anti-inﬂammatory drug; Carrageenan and Alloxan (Sigma Co.,
USA).
Evaluation of the biological activity
Animals
Adult male rats of Sprague-Dawley strain (130–150 g) were
obtained from the laboratory animal facility of the National
Research Center, Dokki, Giza. Animals were housed in steel cages
under standard conditions and fed with standard pellets and
water ad libitum. All experimental procedures were conducted in
accordance with internationally accepted principles for laboratory
animal use and care, and were approved by the Ethics Committee
(No. 9-031) in accordance with recommendations for the proper
care and use of laboratory animals (NIH Publication No. 80-23;
revised 1978).
Evaluation of anti-inﬂammatory activity
The method of Winter et al. (1962) was  adopted, where ten
groups of rats (each of six) were used, eight groups served as the
test groups, each of them was administered a single oral dose of
each of the methanol extract of the eight tested species (A1–A8)
in a dose of 250 mg/kg body weight. The dose of the extracts was
determined as 250 mg/kg on the basis of a preliminary short-term
pilot study with a range of variable doses. The other two  groups,
one of them received 1 ml  saline and served as a negative control
group and the other received Indomethacin, 20 mg/kg body weight
as a reference drug. Drugs were orally administered 1 h prior to car-
rageenan injection. Edema was induced in the rat right hind paw by
subcutaneous injection of 0.1 ml of 1% carrageenan suspension in
saline. Thickness of the right hind paw (mm) was measured imme-
diately before and 1, 2, 3 and 4 h post carrageenan injection with
a micrometer caliber. The results are considered signiﬁcant when
they are different from zero time at p < 0.05.
In vivo diabetic wound healing study
A previously established chemically induced type II diabetic foot
ulcer animal model was employed in this study (Lau et al., 2008).
For those diabetic rats (plasma glucose levels ≥250 mg/dl, samples
collected from tail veins), sixty rats were divided into ten groups,
a standardized wound area (2 mm  × 5 mm skin in full thickness
removed) was  induced on the dorsal surface of the right hind foot
of rats under anaesthetization with phenobarbitone. Eight groups
were treated topically with each of the methanol extract of each of
the eight tested species by topical application on the wounded area.
The other two groups act as a negative (untreated group) and a posi-
tive control group (treated with Dermazine® cream). The treatment
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n each group was started at the day of the operation and contin-
ed till the 10th day. The wounds were covered with appropriate
ressings, which were changed regularly. On changing the dress-
ngs, wounds were inspected, measured and photographed. The
ound areas were measured while animals were under anesthesia
n 2nd, 6th and 10th day after surgery. The progressive changes
n wound area were measured by a plantimeter, wound contrac-
ion were expressed as percentage reduction of original wound
ize [wound area at day 0 − wound area at day n/wound area at
ay 0] × 100.
tatistical analysis
The statistical comparison of difference between the control
roup and the treated groups was carried out using two-way
NOVA followed by Duncan’s multiple range test.
esults and discussion
The classes of compounds were recognizable from their
haracteristic UV spectra, which were identiﬁed based on the
PLC–DAD–ESI–MS/MS data and subsequent conﬁrmation by
omparison with literature data. The chromatographic and spec-
roscopic data summarized in Table 1 and Fig. 1.
hromatographic peaks annotation
henolic acids
Hydroxycinnamic acids such as esters of quinic acid were
etected as about 10 compounds in A. eru, A. grandidentata,  A. brevi-
olia, A. saponaria and A. ferox extracts condensed either with caffeic,
erulic or coumaric acids. The detected mass [M−H]− at m/z 651,
15, 408, 353, 601, 620, 529, 516, 613 and 483 of the peaks, 1 (Rt
18.2 s), 2 (Rt 248 s), 8 (Rt 716 s), 10 (Rt 728 s), 11 (Rt 796 s),
6 (Rt 875.2 s), 17 (Rt 888 s), 23 (Rt 942.1 s), 31 (Rt 976 s), and 38
Rt 1025), respectively. Those peaks showed the characteristic base
eak of quinic acid, ferulic acid, coumaric acid and caffeic acid at
/z 191,193,163 and 179, respectively.
Regarding dicaffeoylquinic acids, peak 2 (Rt 248 s) showed m/z
t 515 [M−H]−, this was identiﬁed as 3,4-di-O-(E)-caffeoylquinic
cid (1). Peak 17 (Rt 888 s) was identiﬁed as 3-O-(E)-caffeoyl-4-O-
eruloylquinic acid (2), it showed [M−H]− at m/z 529 (C26H26O12)
n the negative ionization mode. This parent ion was fragmented
n product ions at m/z 367 base peak, produced by the loss of a
affeoyl unit, and m/z  353, produced by the loss of a feruloyl unit.
affeoylferuloylquinic acid was detected in A. arborescens, A. eru, A.
randidentata and A. perfoliata only. Peak 30 (Rt 970.2 s) showed
M−H]− at m/z at 499 in the negative ionization mode. Peak 30
howed daughter ions at m/z  353, m/z  191 (base peak), m/z 179 and
/z 163. This compound was identiﬁed as 3-O-(E)-caffeoyl-5-O-p-
oumaroylquinic acid (3) (Gouveia and Castilho, 2011), this com-
ound was only detected in A. vera, A. arborescens and A. perfoliata.
Peak 23 (Rt 942.1 s) was identiﬁed as caffeoylquinic hexoside
Gobbo-Neto and Lopes, 2008) and peak 16 (Rt 875.2 s) was likely
dentiﬁed as trans p-coumaric derivative. armacognosia 26 (2016) 352–362
Polyketides
Mass spectrum of peak 3 (Rt 599 s) showed [M−H]− at m/z
393 which showed a daughter ion at m/z 247 due to the loss of
90 amu  as a result of a cross-ring cleavage in the hexosidic part
involved in the formation of the ion at 247. This fragmentation was
previously reported for deprotonated and protonated ﬂavonoid
C-glycosides. Common ions were also noted at m/z  41 and 59
and a neutral loss of 120 amu  was observed. This compound was
identiﬁed as aloesin (4, aloeresin B), which was detected in A. gran-
didentata and A. perfoliata.  This compound was  previously reported
in leaves of A. castanea (Van Heerden et al., 2000). Aloesin A and B
are Aloe resin with no purgative action. Aloesin B is a chromone-
C-glucoside, where aloesin A is a p-coumaric acid ester of
aloesin B.
The negative mode ESI-MS spectrum of peak 13 (Rt 841.9 s)
showed a strong [M−H]− parent ion at m/z 595 corresponding to
the caffeoyl ester of 5-hydroxyaloin A. Fragment ions at m/z 433
and 271 were observed in MS2 consistent with the loss of caffeoyl
and caffeoyl plus carbohydrate moieties from the parent molecules,
respectively. A further fragment ion with m/z  314 corresponds to
the loss of ester group together with a four carbon fragment of the
carbohydrate moiety. Caffeoyl ester of 5-hydroxyaloin A was noted
in A. vera, A. arborescens and A. grandidentata.
Aloeresin C (5) was detected as peak 19 (Rt 915.8 s) showing
[M−H]− at m/z 702, 541 (703-C6H10O5), corresponding to aloeresin
A (6), m/z 394 equivalent to aloesin and m/z 232 corresponding to
aloesone. Aloeresin C represent the ﬁrst example of C,O-diglucoside
of 5-alkylchromoneaglycone detected only in A. vera, A. arborescens,
A. perfoliata,  and A. brevifolia.
Mass spectra of peak 29 (Rt 962.6 s) showed [M−H]− at
m/z 409.1 was identiﬁed as aloenin (7, 4-methoxy-6-(2-ˇ-d-
glucopyranosyloxy-4-hydroxy-6-methylphenyl)-2-pyrone). This
compound was detected only in A. eru.  Aloenin B (8, peak 58, Rt
1290 s), is a bitter glucoside previously isolated from Aloe leaves
and found to exhibit an inhibitory action on gastric juice secretion
of rats (Hirata and Suga, 1978). This compound was detected in A.
vera, A. arborescens, A. eru and A. grandidentata.
The negative mode ESI-MS spectrum of peak 33 (Rt 998 s)
showed a strong [M−H]− parent ion at m/z 433. MS2 of the
compound yielded a daughter ion at m/z 271 resulted from the
loss of a sugar moiety (C6H11O5) from the parent molecules.
A moderately abundant ion at m/z 313 probably results from
the loss of a (C4H8O4) fragment from the [M−H]− parent ion.
Compound 33 was  identiﬁed as 5-hydroxyaloin A (9) (Holzapfel
et al., 1997) and this was only detected in A. grandidentata and
A. perfoliata.
Peak 34 (Rt 1011.9 s) showed [M−H]− at m/z 505 was iden-
tiﬁed as 6′-malonylnataloin (10, nataloin), compound considered
of great importance in systematic discrimination of different Aloe
species. 6-Malonylnataloin is a putative marker for African taxa
in the maculate species complex, although it was  not detected in
Aloe maculata [A. saponaria];  commonly known as the Soap Aloe
or Zebra Aloe; which is a Southern African species of Aloe. On the
contrary, nataloin has been observed in non-maculate species as
diverse in form and infrageneric position as A. vera, A. arborescens,
A. eru, A. grandidentata,  A. brevifolia and A. ferox; those are
related east African species and nataloin may  therefore, serve as a
phytochemical marker for them (Wabuyele, 2006). Comparative
data indicated that the anthrone C-glycoside, 6-malonylnataloin
(7-hydroxychrysaloin 6-O-malonate) is typical of maculate species
in East Africa.
Peak 37 was  identiﬁed as aloinoside A and/or B (stereoiso-
mers of aloin-11-˛-rhamnoside). This was  noted at Rt 1018.4 s
with a deprotonated mass peak at m/z 563.2. This compound was
observed in A. vera, A. arborescens, A. eru, A. grandidentata and
A. perfoliata.
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Table  1
Peak assignments of metabolites identiﬁed in LC/MS spectrum of eight different Aloe species.
No. Rt (s) [M−H]− MSn ion m/z (−) ppm Tentative identiﬁcation A1 A2 A3 A4 A5 A6 A7 A8
1. 118.2 651 591, 501, 436, 349, 302,
206/489, 325, 205, 163, 119
cis-p-Coumaric acid derivatives + + − − − + + +
2.  248 515 464, 382, 301 3,4-di-O-(E)-Caffeoylquinic acid − − − − − − + −
3.  599 393 376, 304, 274, 245, 219, 203,
163
Aloesin (aloeresin B) − − − + + − − −
4.  603 439 380, 313, 274, 135 Unk − + − − + − − −
5.  672 593 431, 258, 175 Aloe emodin-diglucoside − + − + − − − +
6.  677 456 394, 364, 333, 291, 223 Unk − − − + + − − −
7.  698 395 350, 274.8, 230, 202/313, 259,
213
1-Hexanol-pentosylhexoside − − − − + − − −
8.  716 408 315, 252, 147/354, 303, 269,
233
Caffeoyl ferulic acid derivatives − − − + − − − −
9.  727 475 405, 301, 367, 286, 224, 145 Chrysoeriol-7-O-glycuronyl − − − + − − − −
10.  728 353 248, 209, 191, 179, 173, 161,
135, 145
5-O-caffeolyquinic acid − − − − − + − −
11.  796 601 563, 537, 529, 496, 429 Malonyl-3,4-O-dicaffeoyl quinic
acid
+ − − − − − + −
12.  811.8 609 590, 518, 489 Luteolin-6,8-C-diglucoside
(Lucenin II)
+ + − + − − + +
13.  841.9 595 533.1, 433, 415.6, 294.4, 314,
271, 145.1
6′-O-Caffeoyl-5-hydroxyaloin A + + − + − − − −
14.  857.8 542 145.4, 191.8, 250.0, 300.5,
360.9, 415.1, 505, 396
Unk + − − − − − − +
15.  871.2 593 575, 503, 473, 449, 383, 353,
287
Apigenin-6,8-C-diglucoside
(vicenin II)
+ + + + − + − +
16.  875.2 620 583.0, 437.0, 370.8 trans-p-Coumaric derivatives + + − − − − − −
17.  888 529 475, 367, 192, 145 3-O-(E)-caffeoyl-4-O-
feruloylquinic
acid
− + + + + − − −
18.  915.2 667 605, 513, 439, 394, 285, 232 Luteolin-O-xylosylglucoside
malonylated
+ + − + + + + −
19.  915.8 702 541, 395, 233 Aloeresin C (isomer) + + − − + + − −
20.  921 739 704, 587, 577, 550, 453, 310,
289, 242
Epi-catechin digalloyl rhamnoside − − − − + + − −
21.  923.9 624 584.2, 517.0, 314 Isorhamnetin-3-O-
deoxyhexosyl(1-6)
hexoside
+ + − + − + + −
22.  934.8 581 516.2 7-O-Methyl kaempferol dimmer + + − − + − − −
23.  942.1 516 483.9, 354.9, 210.7, 186.7 Caffeoyl quinic acid hexoside + + − − − + − −
24.  945 411 246.8/249, 161, 113 Iso pentyldihexose − − + − − − − −
25.  948 445 439.6, 409, 248.8, 271, 269, 153 Apigenin-7-O-glycuronyl − − + − − − − −
26.  948.2 579 495.1, 447.4, 356.9, 287, 285 Kaempferol-3-O-hexosyl-O-
pentoside
− + + − − − −
27.  948.2 447 357.3/405, 327, 147 Luteolin-8-C-glucoside (orientin) + + − + + − − +
28.  955.6 447.8 429.8, 405, 356.9, 326.9, 271,
147
Luteolin-6-C-glucoside
(isoorientin)
+ − − + − − − −
29.  962.6 409.1 247 Aloenin − − + − − − − −
30.  970.2 499 472.0, 436.7, 312.5 3-O-Caffeoyl-5-O-coumaroylquinic
acid
+ + − − + − − −
31.  976 613 570, 508, 457, 391 4-Succinyl-3,4-dicaffeoylquinic
acid
− + − − + + + −
32.  998 469 435/395, 298, 192, 149 Unk − − − + − − − +
33.  998 433 396.6, 342.9, 313, 269.8, 271,
255
5-Hydroxyaloin A − − − + + − − −
34.  1011.9 505 448, 343.1, 342.9, 341.1, 172 6′-Malonylnataloin (nataloin) + + + + − + − +
35.  1013.1 343 316, 315, 299, 287, 285, 236 5,3′-Dihydroxy-6,7,4′-trimethoxy
ﬂavones (Eupatorin)
− + + + − + − −
36.  1018.1 463 515.8, 472.5/301 Isoquercetrin − + + − − − − −
37.  1018.4 563.2 505.5, 500, 435, 406, 342.9,
328, 290
Aloinoside A/B + + + + + − − −
38.  1025 483 446, 422, 325.9/337, 319, 173,
163
3,4-Di-O-(E)-p-coumaroylquinic
acid
− + − + − − − −
39.  1057 577 451, 425, 413, 305, 271, 293.4 Epi (afzelechin) – (epi)
gallocatechin
− − + + + − − −
40.  1063 543 500, 462, 361 Unk + + − + − − − −
41.  1081 509 492.6, 387.9, 345.9, 283.8,
212.9
Unk + + − − − − − −
42.  1084.2 506 396.5, 343.0, 342.9 Unk + + − − − − − −
43.  1096 570 548, 510.8, 471.9, 433, 411,
357.5, 320, 248, 203
2′-O-Feruloylaloesin − + + + − + + −
44.  1114 778 658, 570, 508, 455 Unk − − − + + − − −
45.  1120.5 616 582.7, 578.8, 516.8, 500.1,
393.2, 147.1, 145.3
7-O-Methylaloesin-penta acetate + + − − + − + −
46.  1121 583 570, 554, 477, 407, 243, 272 7-Methylether of 2′-feruloylaloesin − − + + − − + −
47.  1143.7 604 567.1, 500.3, 421.0 malonyl-4,5-O-dicaffeoylquinic
acid
+ + − − − − − −
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Table 1 (Continued)
No. Rt (s) [M−H]− MSn ion m/z (−) ppm Tentative identiﬁcation A1 A2 A3 A4 A5 A6 A7 A8
48. 1161 629 547, 481, 208, 146/537, 425,
378, 325, 236, 178, 146
Glucuronides − − + − + − − −
49.  1164 670 616, 550, 473, 274 Unk − − − − − − + +
50.  1167 555 538, 512, 410, 392, 366, 259,
193, 147, 119
Isoaloeresin D − − + + + + − −
51.  1198 554 – Unk − − − + + − − −
52.  1224.4 556 494, 423, 282, 207 Aloeresin − − + + − + − −
53.  1226 671 615, 581, 481 Unk − − − + − − − +
54.  1256.4 418 417.6, 343.2 Nataloin + + − + − − − −
55.  1258 297 – Veracylglucan A − + − − − − − −
56.  1265 885 431, 307, 284 Kaempferol di
deoxyhexosylhexoside
− − + − − − − +
57.  1281.6 833 636.2, 713.5, 775.6 Unk + + − + − − − −
58.  1290 713 635.9, 564.3, 516.5, 343.4 Aloenin B + + + + − − − −
59.  1292.0 747 482.1 Wighteone-O-diglucoside
malonylate
+ + − − − − − −
60.  1302.1 417 396.1, 343.1, 296.9 Aloin A + + − + − − − −
61.  1318 417 145, 297, 343 Aloin B + − − + − − − −
62.  1328 432 361, 359, 353, 340.7, 310, 283,
269
Isovitexin (6-C-glucosyl-apigenin) − − − − + − − −
63.  1342 539 432, 359, 312, 254, 146 6′-O-Coumaroyl aloesin − − − − + − − −
64.  1366 297 248.9, 174.9 Hydroxy octadecenic acid − − − + − − − −
65.  1396 586.9 587, 518.1, 427, 257, 147 Unk − − + − − − − −
66.  1407 540 468, 420, 393, 312 Aloeresin A isomer − − − − + − − −
67.  1410 329.7 286, 214, 147 Trihydroxy octadecenoic acid − − − − − − + −
68.  1424 1016 979, 916.9, 859.6, 834.9, 606,
144.8
Unk + + − − − + − −
69.  1430 657.6 620, 530, 458/533, 480, 391,
134
Unk − − − + + − − −
70.  1448 869.2 833, 717, 650, 586.3, 511.3,
144.7
Unk + + − + − − − −
71.  1460 569 426, 355, 285, 225, 161 Caffeoylester of aloesin − + + − + − − −
72.  1462 496 418, 225, 397, 285, 248, 145 Unk − + + − − − − −
73.  1507 580 463, 326, 296, 265 Unk − − − + − + − −
74.  1519 605 562, 425, 317, 267, 146, 92 Unk − − + − − + − −
75.  1590 565 534, 488, 343, 241 Trihydroxycinnamic acid
derivatives
− − − + − − − −
76.  1600 599 564, 512, 443.0 Unk + + − + − − − −
77.  1611 685 623, 571, 500, 523.3, 539, 521 Aloeresin E + + + + + - - +
78.  1612 557 505, 444, 392, 322, 251 Acetyl dicaffeoylquinic acid − − − + + − − −
79.  1645 831.3 813.2, 711.2, 669.8, 742, 686,
553
Unk + + − − − − − +
80.  1659.9 416.4 267.8 Barbaloin (10R)/Isobarbaloin (10S) + + − − − − − −
81.  1666 445 380, 295, 256, 216, 145/269 Apigenin-7-O-glycuronyl − − + − − − − −
82.  1725 741.6 416, 301, 300/609, 301 Quercetin pentosyl rutinoside − − − − − − − +
83.  2083 689.1 854, 603, 505 Unk − + − − + + − −
84.  2097 675.9 640, 586, 534/640, 506, 497 Unk − − − − + + + −
85.  2117.8 711.9 675.2, 550.6, 396.9 Quercetin-7-O-hexoside-3-O-
malonylhexoside
+ + − − + − + −
86.  2174 431 316.1, 269, 225 Aloe-emodin-8-O-glucoside + + + − + − + +
87.  2226 553 408, 376, 341, 275, 259, 256,
233, 193, 178, 161
2′-p-Methoxycoumaroylaloresin − − + − + − + −
88.  2235 552 448.1, 359.8, 145.1 Unk − + − − + − − −
89.  2252 715 625.6, 553.6, 455.1, 357.6,
303.8, 207, 129.2
Unk − + − − − − − −
90.  2293 567 528, 313, 271, 253, 169 Chrysophanol-8-O-(6′-O-galloyl-)
glucoside
− + − − − − − +
91.  2339 637 579, 504, 359 Unk − − − − − − + −
92.  2450 825 788, 669, 626, 581, 514, 452,
394
Aloeresin H tetra-O-methyl ether − − − − − − + −
93.  2549 769 730.5, 326.1 Aloeresin H − + − − + − − −
94.  2574 612 555, 492.3, 427, 260.4 Unk + + + − + − − −
95.  2603 642, 643 612, 557, 513, 446, 375, 269,
135/550, 501/580, 508, 459
Unk − − + − + − + +
96.  2625 809.8 642, 556, 515, 448 Unk + + − − + − + −
97.  2632 444.2 392, 203.7 Unk + + − − − − − −
98.  2650 811.8 777.8, 672.4, 573.3, 512.8,
462.3, 392, 341, 269, 135
Unk − + − − + − − −
99.  2712 813.4 529.4, 462.4 Unk − + − − + − − −
100.  2768 789.6 672.3, 612.6, 533.9, 467, 398.7,
308.8, 272, 135, 93
Unk − + − − − − − −
101.  2871 627.8 571.2, 505.8, 444.8, 388.7,
135.6/481, 319
Pentahydroxyﬂavonol-O-hexosyl
rhamnoside
− + − − + − − −
102.  2872 532/533 464, 388, 171/489, 285 Kaempferol-3-O-malonylhexoside − − − + + − − −
A1 = Aloe vera, A2 = A. arborences, A3 = A. eru, A4 = A. grandidentata, A5 = A. perfoliata, A6 = A. brevifolia, A7 = A. saponaria,  A8 = A. ferox. Unk = unknown.
(+)  denotes presence and (−) denotes absence of each compound in examined Aloe species
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Fig. 1. HPLC ﬁngerprint of A, Aloe vera; B, A. arborences; C, A. eru, D, A. grandidentata; E, A. perfoliata; F, A. brevifolia; G, A. saponaria, H, A. ferox recorded at 254 nm.
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ESI-MS spectrum of peak 45 (Rt 1120.5 s) showed [M−H]− at m/z
16 which on further fragmentation yielded ions at m/z 516, 500,
93 and 147. This compound was identiﬁed as 7-O-methylaloesin
enta acetate and detected in A. vera, A. arborescens, A. perfoliata
nd A. saponaria.
The negative ESI-MS of peak 46 (Rt 1121 s) showed strong
eaks at m/z 583 [M−H]− which yielded a peak at m/z 407
M−177]− due to the loss of a fragment with mass 177. This
ould be interpreted as the loss of a (COCH CHC6H3 (OCH3) OH)
ragment from a ferulic acid derivative. This fragmentation is fol-
owed by the loss of water from m/z 407. The spectrum showed
o peaks corresponding to the subsequent loss of the carbohy-
rate moiety after the loss of the acyl group. In contrast, the
egative ESI-MS of aloesin showed a strong [M−H]− ion and a
ase peak at m/z 272 corresponding to the loss of carbohydrate
oiety. This compound was identiﬁed as (E)-2-acetonyl-8-(2′-O-
eruloyl)--d-glucopyranosyl-7-methoxy-5-methylchromone (11,
-methylether of 2′-feruloylaloesin) and detected in A. eru, A. gran-
identata and A. saponaria.  7-Methylether of 2′-feruloylaloesin was
reviously reported in the leaves of A. broomii, A. Africana and A.
peciosa (Holzapfel et al., 1997).
Peak 50 (Rt 1167 s) revealed a molecular ion peak at
/z 555 [M−H]−, consistent with a molecular weight 556
hich was detected in A. eru, A. grandidentata,  A. perfoli-
ta and A. brevifolia. MS/MS  analysis revealed the follow-
ng fragments at m/z 538 [M−H2O] ([M−18]−), m/z 512
M−CH3CHO] ([M−44]−), m/z  410 [M−coumaroyl] ([M−146]−),
/z 392 [M−(146 + 18)]−, m/z  366 [M−(146 + 44)]−, m/z 259
M−(133 + 146 + 18)]−, m/z 193[M−(133 + 146 + 84)−], m/z 147
coumaroyl]+ and m/z 119 [HOC6H4CHCH]+. This spectra was
onsistent with the spectrum reported by Lee et al. (2000) for
soaloeresin D (12,  8-C--d-[2-O-(E)-coumaroyl]glucopyranosyl-
-[2-hydroxy]-propyl-7-methoxy-5-methyl chromone).
Nataloin was detected as peak 54 (Rt 1256.4 s) with [M−H]−,
t m/z 418, this compound was observed in A. vera, A. arborescens
nd A. grandidentata.  Aloin A/B (13, 10-C--d-glycopyranoside of
loe-emodin-anthrone), which in most cases was detected as a mix-
ure of - and -stereoisomers (MW  418), was previously isolated
rom the leaf exudates of the non maculate Kenyan species (Conner
t al., 1987). Aloin A was observed in the leaf extract of A. vera, A.
rborescens, and A. grandidentata as peak 60 with [M−H]− at m/z
17. Peak 61 (Rt 1318 s) which showed [M−H]− at m/z  417 was
dentiﬁed as aloin B and was detected in A. vera and A. grandidentata.
Peak 63 (Rt 1342 s) was identiﬁed as a chromone; 6-O-
oumaroyl aloesin having [M−H]− at m/z 539 which was  detectedarmacognosia 26 (2016) 352–362
only in A. perfoliata. This chromone is a marker metabolite restricted
to the section Anguialoe,  thus providing chemotaxonomic corrob-
oration for the presumed monophyly of the section (All species of
Aloe that belong to section Anguialoe share a single, unique apo-
morphy which is the sessile ﬂowers) (Reynolds, 1985).
Peak 66 (Rt 1407 s) with [M−H]− at m/z 540 consistent with a
molecular weight 541 of aloeresin A (6). The daughter fragment at
m/z 393 with difference 146 amu  was  in agreement with the loss
of a p-coumaroyl group. In previous work dealing with the mass
spectral characterization of plant glycoconjugates, a neutral loss
of 120 amu  due to a cross-ring cleavage in the hexosidic part for
deprotonated and protonated ﬂavonoids C-glycosides was reported
(Wang et al., 2003). The latter loss has also been reported for the
protonated chromone C-glycosides, aloesin and aloeresin A. Alo-
eresin A was  detected only in A. perfoliata.
Mass spectra of peak 71 at (Rt 1460 s) showed [M−H]− at
m/z 569 which was  tentatively interpreted as caffeoyl ester of
aloesin. The compound was  identiﬁed as (E)-2-acetonyl-8-(2′-
O-caffeoyl)--d-glucopyranosyl-7-methoxy-5-methyl chromone
and observed in A. arborescens, A. eru and A. perfoliata.  Peak
77 (Rt 1611 s) showed [M−H]− at m/z 685 which was
tentatively interpreted as (E)-2-acetonyl-(2′,6′-di-O,O-coumaroyl)-
-d-glucopyranosyl-7-hydroxy-5-methyl chromone (aloeresin E,
14). This compound was  observed in A. vera, A. arborescens,  A. eru,
A. grandidentata,  A. perfoliata and A. ferox. MS2 showed daughter
fragment ions at m/z 539 and 521 corresponded to the loss of
acetonyl and coumaroyl plus carbohydrate moieties from the par-
ent molecules, respectively. Mass spectrum of peak 86 (Rt 2174
s) showed [M−H]− at m/z 431 which was tentatively interpreted
as aloe-emodin-8-O-glucoside (14). MS2 of the compound showed
fragment ions at m/z 316, 269, and 225. This was  detected in A. vera,
A. arborescens, A. eru, A. perfoliata, A. saponaria and A. ferox.
Peak 87 (Rt 2226 s) in the negative ion mode showed a depro-
tonated parent ion peak at m/z 553 [M−H]−. A daughter ion was
obtained in MS2 due to loss of p-methoxy coumaric acid at m/z  376
and the presence of the p-methoxy coumaroyl fragment ion at m/z
161 which were consistent with the previously reported data for 2′-
p-methoxy coumaroylaloeresin in leaves of A. excels (Mebe, 1987).
This compound was detected in A. eru, A. perfoliata and A. saponaria.
The ESI-MS spectrum of peak 92 (Rt 2450 s) gave deprotonated
molecule [M−H]− at m/z 825 which was tentatively interpreted
as aloeresin H tetra-O-methylether observed only in A. saponaria.
For peak 93 (Rt 2549 s), the ESI-MS spectrum gave deprotonated
molecule [M−H]− at m/z 769 which was  tentatively interpreted as
aloeresin H (C,C-di-glucoside polyketides) and observed only in A.
arborescens and A. perfoliata.
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-glycosylﬂavonoids
The occurrence of ﬂavonoids such as isoorientin (15, luteolin-
-C-glucoside) and isovitexin (16, apigenin 6-C-glucoside) was
bserved in biogeographical trends. Isoorientin is a common con-
tituent of tropical and sub-tropical species of Aloe, whereas
sovitexin is restricted to a few southern African species. Isoorientin
nd isovitexin co occur in the Southern African maculate species;
. parvibracteata,  and the disjunct West African maculate species,
. macrocarpa. The presence of isoorientin and isovitexin in mac-
late species of Aloe was ﬁrst reported by Grace et al., 2010. The
resence of ﬂavonoids in section Pictae is therefore of taxonomic
nterest.
ESI-MS spectrum of Peak 12 (Rt 811.8 s) showed [M−H]− at
/z 609, its MS/MS  spectrum give rise to daughter ions at m/z
90 [(M−H)-18]−, 518 [(M−H)-90]− and a base peak at m/z 489
(M−H)-120]−. This compound was tentatively characterized as
uteolin-6,8-C-diglycoside (17, lucenin II). The MS/MS  spectrum
f peak 15 (Rt 871.2 s) in negative ion mode with [M−H]− at
/z 593 which produced daughter ions at m/z 575 [(M−H)-18]−,
/z 503 [(M−H)-90]− and a base peak at m/z 473 [M−H-120]−,
xhibiting a fragmentation pattern of ﬂavones di-C-glycoside. The
ons at m/z 353 [(M−H)-(120 + 120)]− and at m/z 383 [(M−H)-
90 + 120)]− indicated the presence of apigenin (MW  270) as
glycone and two hexose moieties (glucoses). Comparing with MS
iterature data (Piccinelli et al., 2008), this compound was  charac-
erized as 6,8-di-C-glucosylapigenin and also known as vicenin II
18).
Peak 27 (Rt 948.2 s), showed ESI-MS spectrum with [M−H]−
t m/z 447. Tendam mass of this peak yielded fragment ions at m/z
57.3 [(M−H)-90]− and a base peak at 327 [(M−H)-120]−, together
ith the absence of the loss of 18 amu  suggesting that the mono-
-glycosylation is in position 8 (Ferreres et al., 2007). Peak 27 was
entatively characterized as luteolin 8-C-glucoside, also known as
rientin (19). This compound was detected in A. vera, A. arborescens,
. grandidentata,  A. perfoliata and A. ferox. ESI-MS spectrum of peak
8 (Rt 955.6 s) showed a deprotonated molecule [M−H]− at m/z
47.8. The spectrum exhibited fragments at m/z  356.9 [(M−H)-90]−
nd a base peak at 326.9 [(M−H)-120]−. For ﬂavones mono-C-
exosides, the position of the sugar residue can be assigned through
bservation of the abundance of fragment ion [(M−H)-18]. In gen-
ral, the fragmentation of the 6-C-isomers is more extensive, giving
n ion corresponding to m/z 429 [(M−H)-18]−, probably due to the
ormation of an additional hydrogen bond between the 2′′-hydroxyl
roup of the sugar and the 5- or 7-hydroxylgroup of the agly-
one, which confers additional rigidity (Abad-Garcia et al., 2009).
he abundance of fragment ion at 429.8 suggested the mono-C-
lycosylation is in position 6, hence, compound 28 was  identiﬁed as
uteolin-6-C-glucoside, also known as isoorientin (15). Isoorientin
as detected in A. vera and A. grandidentata.
Peak 62 at Rt 1328 s, in which the ESI-MS spectrum showed
M−H]− at m/z  432 was characterized as 6-C-glycosyl apigenin,
lso known as isovitexin (16). Its MS/MS  spectrum gave mass frag-
entation at m/z 340.7 and 310. Isovitexin was observed only in A.
erfoliata. The main product ions in the negative ionization mode
ere due to dehydration, cleavage of sugar ring, and the loss of
lycosidic methyl group as formaldehyde. In addition, the inten-
ity ratios of these major fragments could be a way  to differentiate
itexin from isovitexin (Abad-García et al., 2008). The MS/MS  in the
egative ionization mode, the product ions obtained with cleav-
ge of sugar ring was proposed as diagnostic ions, since m/z 313
s the base peak of apigenin-8-C-glycoside and m/z  283 is the base
eak of apigenin-6-C-glycoside. In contrast, an ion at m/z 361 was
nly found in apigenin-6-C-glycoside, probably because of the addi-
ional hydrogen bond that is required for loss of the extra water
Abad-García et al., 2008).armacognosia 26 (2016) 352–362 359
 
O-Glycosylﬂavonoids
Peak 9 showed precursor ions at m/z 475 [M−H]− and MS2 at
m/z 301, corresponding to the loss of a glycuronyl unit. A further
fragmentation of the precursor ion at m/z 301 resulted in a prod-
uct ion at m/z 286, produced by the loss of methyl group (El-Hela
et al., 2010). Therefore, peak 9 was  identiﬁed as chrysoeriol-7-O-
glycuronyl detected only in A. grandidentata.
MS  spectra interpretation allowed the assignment of the com-
pound luteolin-O-xylosylglucoside malonylated as peak 18 and its
molecular ion at m/z 667 and further fragmentation of parent ion
which gave aglycone fragment at m/z 285 as the most abundant
ion in the fragmentation spectrum (Wojakowska et al., 2013) indi-
cating the presence of luteolin. Malonylation increase both the
afﬁnity and transportation, of anthocyanins or other ﬂavonoids
and facilitate their transport into the vacuole by a deﬁned trans-
porter. It has been suggested that aromatic acylation enhances the
color of anthocyanins, whereas aliphatic acylation (usually mal-
onylation) may  stabilize ﬂavonoids and increase the resistance of
ﬂavonoid glucoside malonates to enzymatic degradation (Luo et al.,
2007). Malonylation of ﬂavonoids occurs widely in plants, and mal-
onyltransferases have been characterized from several different
species (Yu et al., 2008). Malonylation, but not p-coumaroylation,
of ﬂavonoids induces a conformational change that might facili-
tate their transport and storage in the vacuole, possibly through
improved solubility and reaction with other vacuolar components
(Matern et al., 1983). Compound 18 was  observed in all of the
investigated Aloe species except A. eru and A. ferox. The presence
of ﬂavonoids in section Pictae is of taxonomic interest.
Peak 21 (Rt 923.9 s) was identiﬁed as isorhamnetin derivative.
Isorhamnetin is a methylated derivative of quercetin and it was
identiﬁed on the basis of the presence of a speciﬁc base peak at
m/z 314, in addition to characteristic loss of a methyl from its
methoxy group (−15 amu). The results were consistent with the
loss of a deoxyhexosyl-hexoside moiety (308 amu). Compound 21
was identiﬁed as isorhamnetin-3-O-deoxyhexosyl-(1-6) hexoside
and was noted in A. vera, A. arborescens, A. grandidentata,  A. brevifolia
and A. saponaria.
The mass spectrum of peak 25 at (Rt 948 s) showed precursor ion
in the negative ionization mode at m/z 445 [M−H]− and a daugh-
ter ion peak at m/z 269, corresponding to the loss of a glycuronyl
unit. Therefore, this compound was identiﬁed as apigenin-7-O-
glycuronyl (Surowiec et al., 2007; Petroviciu et al., 2010) noted only
in A. eru.
Mass spectrum of peak 26 (Rt 948.2 s) showed precursor ions
at m/z 579 [M−H]− could be identiﬁed as a kaempferol-hexosyl-
pentoside based on the fragment at m/z 447 [(M−H)-132]− and
at m/z 285 [(M−H)-132-162]−. Therefore, peak 26 was  identi-
ﬁed as kaempferol-3-O-hexosyl-pentoside. It is important to note
that product ion at m/z 287 showed a fragmentation pattern in
360 A.M. El Sayed et al. / Revista Brasileira de Farmacognosia 26 (2016) 352–362
Table 2
Anti-inﬂammatory activity of the methanol extract of the eight Aloe species (A1–A8).
Time (h) Zero 1 h 2 h 3 h 4 h
Group Paw
diameter
(mm)
Paw
diameter
(mm)
Edema
thickness
(mm)
Edema
thickness
(mm)
Paw
diameter
(mm)
Edema
thickness
(mm)
Paw
diameter
(mm)
Paw
diameter
(mm)
Edema
thickness
(mm)
Control 3.30 ± 0.08 4.41 ± 0.1a 1.11 4.71 ± 0.13a 1.41 4.81 ± 0.12a 1.51 4.85 ± 0.07a 1.55
A.  vera 3.33 ± 0.08 4.26 ± 0.10a 0.93 4.10 ± 0.13a 0.77 3.82 ± 0.12a 0.49 3.64 ± 0.08a 0.31
A.  arborences 3.49 ± 0.09 4.34 ± 0.09a 0.85 4.21 ± 0.08a 0.72 4.03 ± 0.09a 0.55 3.84 ± 0.09a 0.35
A.  eru 3.51 ± 0.10 4.38 ± 0.14a 0.87 4.28 ± 0.14a 0.77 4.12 ± 0.14a 0. 61 3.94 ± 0.11a 0.43
A.  grandidentata 3.56 ± 0.11 4.16 ± 0.20a 0.6 3.99 ± 0.10a 0.43 3.95 ± 0.05a 0.39 3.90 ± 0.7a 0.34
A.  perfoliata 3.57 ± 0.1 4.46 ± 0.12a 0.89 4.27 ± 0.14a 0.70 4.04 ± 0.05a 0.47 3.94 ± 0.05a 0.37
A.  brevifolia 3.49 ± 0.06 4.37 ± 09a 0.89 4.30 ± 0.06a 0.81 4.27 ± 0.07a 0.78 4.03 ± 0.6a 0.54
A.  saponaria 3.61 ± 0.02 4.51 ± 0.07a 0.90 4.38 ± 0.02a 0.87 4.14 ± 0.08a 0.53 4.08 ± 0.06a 0.47
A.  ferox 3.60 ± 0.09 4.49 ± 0.09a 0.89 4.31 ± 0.08a 0.71 4.11 ± 0.09a 0.51 3.98 ± 0.09a 0.38
Indomethacin 3.56 ± 0.08 4.12 ± 0.09a 0.6 3.99 ± 0.06a 0.43 3.92 ± 0.01a 0.36 3.84 ± 0.07a 0.28
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he dose of the extracts was  250 mg/kg.
greement to kaempferol (Cuyckens and Claeys, 2004; Vallverdú-
ueralt et al., 2010).
Mass spectrum of peak 35 (Rt 1013.1 s) showed [M−H]− at
/z 343, it was identiﬁed as dihydroxyl trimethoxyﬂavone (5,3′-
ihydroxy-6,7,4′-trimethoxyﬂavone) Eupatorin and noted in A.
rborescens, A. eru, A. grandidentata and A. brevifolia. MS/MS  spec-
rum gave product ions at m/z 316, 315, 299 and 287, which
ere in accordance to this compound (Jaffer and Mahmoud, 2011;
kowuah et al., 2012).
Peak 36 (Rt 1018.1 s) showed [M−H]− at m/z 463 consis-
ent with the molecular formula (C21H20O12). MS/MS  spectrum
f this compound showed a product ion at m/z 301 indicating a
uercetin nucleus (Breiter et al., 2011). This peak was compared
ith authentic standard and identiﬁed as quercetin-3-O-glucoside
isoquercetrin) and was noted only in A. arborensis and A. eru.
HPLC analysis of the methanol extract of the leaves of the eight
nvestigated Aloe species revealed apart from the known metabo-
ites; aloesin (4), nataloin (10), aloin A/B (13), aloeresin E (14)
nd aloeresin H, which are of particular importance in the chemo-
axonomic study of the genus Aloe. Barbaloin/isobarbaloin, which
s C-glucoside of aloe emodin anthrone (10--d-glucopyranosyl-
,8-dihydroxy-3-hydroxymethyl-9 (10H)-anthracenone) are con-
idered to be the most speciﬁc secondary phytoconstituent in Aloe
pecies. Barbaloin has been found to have a strong inhibitory effect
n histamine release from mast cells (Patel et al., 2012). Alo-
resin H, 8-C--d-glucopyranosyl-7-hydroxy-5-methylchromone
ortion that is common to all aloeresins (A–G) were detected in
ost of the investigated Aloe species. Aloeresin Hrepresents the
rst C,C-diglucosylated molecule discovered in Aloe spp. extracts.
lthough cinnamic acid derivatives are present in Aloe metabolites
n the aloin series, aloeresin E (14) and aloeresin F represent the
rst cinnamic acid derivatives in the aloeresin series of metabolites
able 3
ffect of the methanol extract of the eight Aloe species on wound area in diabetic rats.
The tested sample 
Zero time Day 2 
Control 1.53 ± 0.003 1.55 ± 
A. vera 1.58 ± 0.001 1.26 ± 
A. arborences 1.63 ± 0.002 1.23 ± 
A. eru 1.67 ± 0.002 0.89 ± 
A. grandidentata 1.71 ± 0.001 1.49 ± 
A. perfoliata 1.69 ± 0.003 1.41 ± 
A. brevifolia 1.56 ± 0.001 1.45 ± 
A. saponaria 1.68 ± 0.002 1.34 ± 
A. ferox 1.51 ± 0.001 1.37 ± 
Dermazine® 1.65 ± 0.004 0.72 ± 
a Signiﬁcantly different from zero time at p < 0.05 (n = 6).(Van Heerden et al., 1996). Aloenin B (8), a new bitter glycoside was
detected in most of the leaves of the investigated Aloe species. 6′-
Malonylnataloin (10), a malonylated derivative of the rare anthrone
nataloin, also was  identiﬁed in all investigated samples of Aloe.
Anthrone C-glycosides are among a suite of chemical constituents
of systematic importance in Aloe.
Aloe has long been recognized by different pharmacopeias over
the world as a purgative drug (Rowson et al., 1967; Osol et al.,
1973). The purgative effects of Aloe leaf (drug aloes) have been
attributed to anthraquinone C-glycosides, notably barbaloin, aloin
A and B (Steenkamp and Stewart, 2007). Further studies were
conducted to investigate the Aloe’s constituents responsible for
this activity. Anthranol, aloe-emodin, chrysophanic acid (chryso-
phanol), aloin (barbaloin) and p-coumaric acid were previously
reported in A. vera. A thin layer chromatographic study of 22 species
of Aloe (Meredova et al., 1973) showed that twelve species contain
ﬂavonoids, hydroxy anthraquinones and coumarin.
Concerning the diabetic wound healing effect of the methanol
extracts of the eight investigated Aloe species, results obtained in
the present study suggested that treatment of diabetic rats with
the methanol extract of each of the eight studied Aloe species may
have a beneﬁcial inﬂuence on wound healing. It is noteworthy
to mention that the eight investigated species showed signiﬁcant
anti-inﬂammatory activity (Table 2) as their action in reducing the
thickness of edema started from the ﬁrst hour and continued for
the four hours. The anti-inﬂammatory activity of Aloe may  be due
to the inhibition of the cyclooxygenase pathway and reduction
of prostaglandin E2 production this could be attributed to its C-
glucosyl chromones (Hutter et al., 1996). The ﬁndings of our study
conﬁrmed the signiﬁcant acceleration of diabetic wound healing
in rats following topical application of the methanolic extract of
the leaves of the various Aloe species. The healing effect on the
Wound area (cm2)
Day 6 Day 10
0.002 1.59 ± 0.001a 1.60 ± 0.003a
0.004a 0.69 ± 0.003a 0.36 ± 0.001a
0.002a 0.67 ± 0.001a 0.46 ± 0.001a
0.003a 0.46 ± 0.001a 0.23 ± 0.001a
0.002a 1.13 ± 0.002a 0.74 ± 0.001a
0.001a 0.86 ± 0.001a 0.53 ± 0.001a
0.001a 0.81 ± 0.002a 0.63 ± 0.002a
0.002a 0.65 ± 0.001a 0.31 ± 0.001a
0.003a 0.98 ± 0.001a 0.47 ± 0.002a
0.001a 0.43 ± 0.002a 0.13 ± 0.001a
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Table  4
Percent of change in wound area in diabetic rats treated with methanol extract of
the  eight Aloe species.
The tested samples % of change in wound area
Day 2 Day 6 Day 10
Control 1.31 3.92 4.6
A. vera 30.30 56.3 77.2
A.  arborences 24.5 58.8 71.8
A.  eru 46.71 72.9 86.2
A.  grandidentata 12.9 33.9 57.9
A.  perfoliata 17.2 59.2 68.6
A.  brevifolia 7.1 48.1 59.6
A. saponaria 20.2 61.3 81.6
A.  ferox 14 35.1 68.9
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iabetic wounds was observed for the topical application of the
ethanol extracts of the eight studied Aloe species (Table 3), how-
ver, A. eru showed the highest effect in reducing the wounds
rea which reached 86.2% by day 10 (Table 4). It was previously
eported that the healing properties of Aloe could be attributed to
ts glucomannan type polysaccharide, which stimulates the activ-
ty of ﬁbroblasts and causes proliferation, which in turn increases
ollagen synthesis (Chithra et al., 1998). The high wound healing
ctivity observed for A. eru could be mainly attributable to its major
onstituent aloenin, which was reported to signiﬁcantly promote
air growth and demonstrated recuperative effects on human skin
Wolfson and Gutterman, 2009). Aloenin was detected only in A.
ru (Table 1).
onclusion
The occurrence of ﬂavones-C-glycosides, heptaketides (e.g.
-methylchromones) and octaketides (e.g. 1,8-dihydroxy-9-
nthrones) in Aloe species is known. The results obtained here
howed that these species possess different chemical composition,
ustifying the importance of studies aiming for the chemical
haracterization of different Aloe species. The anti inﬂammatory
nd wound healing activity of the Aloe species has been attributed
o polyphenolic compounds. A. eru showed the highest effect in
educing the wounds area in ten days which is rich in Aloenin.
mong the species presented in this paper, ﬂavonoids are found
s main constituents specially lucienin II, vicenin II, orientin and
sovitexin in A. vera, A. arborescens, A. grandidentata,  A. perfoliata,  A.
revifolia and A. saponaria.  Heptaketides (5-methylchromones) are
ound as main constituents in all investigated Aloe species except A.
era, A. perfoliata and A. ferox. Polyketides are of chemotaxonomic
nterest in all Aloe species investigated.
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